Related Experiment Video
Updated: Jul 25, 2026

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
Sudden cardiac death: opportunities for prevention
Insights
Expanded implantable cardioverter-defibrillator (ICD) guidelines are needed in the UK. This review suggests updated indications to broaden patient access to life-saving ICD therapy.
Area of Science:
- Cardiology
- Medical Device Therapy
- Clinical Guidelines
Background:
- Current evidence for implantable cardioverter-defibrillator (ICD) therapy necessitates broader clinical indications.
- UK physicians require updated guidance to treat a wider spectrum of patients eligible for ICD implantation.
Discussion:
- Review of existing ICD clinical guidelines and evidence base by NICE consultees.
- Analysis of the current UK strategy for ICD implantation.
Key Insights:
- The existing evidence supports expanding ICD indications.
- A revised UK ICD implantation strategy is proposed.
Outlook:
- Facilitating broader patient access to ICD therapy through updated guidelines.
- Enhancing the management of cardiac arrhythmias and sudden cardiac death prevention in the UK.
Abstract:
The evidence base for implantable cardioverter-defibrillator (ICD) therapy requires expansion of guidance/indications to allow UK physicians to treat a broader range of patients. The ICD clinical consultees to the National Institute for Health and Clinical Excellence (NICE) review current guidance/guidelines, explain the evidence base, and suggest a UK ICD implantation strategy.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Introduction Cardiac Emergencies
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy III: Hypertrophic Cardiomyopathy

